Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative

MENLO PARK, Calif . -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that the Wellcome Sanger Institute has committed to purchase seven new Sequel IIe Systems and upgrade its five existing Sequel II Systems to increase its long-read sequencing capabilities for projects including the Darwin Tree [...]

QIAGEN announces appointment of new Supervisory Board member

Dr. Toralf Haag appointed to Supervisory Board and a member of the Audit Committee Venlo, the Netherlands – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Dr. Toralf Haag has been appointed a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was [...]

Emulate Announces Organ-on-a-Chip Application and Services Roadmap

Expanded In Vitro Modeling Tools Will Enable Researchers to Better Understand the Effects of Advanced Biologics and Gene Therapies BOSTON, Mass. - Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on [...]

SARS-CoV-2 Antigen Protein Kits

AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates.SARS-CoV-2 is an enveloped positive-stranded RNA virus that consists of four structural [...]

Merck Announces Formation of Merck Digital Ethics Advisory Panel

Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. DARMSTADT, GERMANY Panel designed to provide ethical counsel to inform all business processes, supporting the evolving data-driven, digital landscape Merck, a leading science and technology company, today announced the creation of its [...]

GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology

BILLERICA, Mass. --  Bruker Corporation (Nasdaq: BRKR) today announced that three world-leading institutions are now accelerating their research into functional structural biology and human disease with new Bruker ultra-high field nuclear magnetic resonance (NMR) spectrometers installed in 2020. Novel GHz-class NMR technology enables advanced research to obtain structural, functional and binding information of intrinsically disordered proteins [...]

PerkinElmer to Acquire Oxford Immunotec Global PLC

PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 WALTHAM, Mass. & LONDON -- PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) ("Oxford Immunotec" or the “Company”) are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford [...]

Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls

SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it will supply the U.S. Centers for Disease Control and Prevention (CDC) with a customized version of Twist SARS-CoV-2 Synthetic RNA Controls for use in the [...]

Abcam and Shuwen extend strategic alliance in China to develop companion diagnostics

Cambridge, UK and Deqing, China : Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, and Shuwen Biotech (Shuwen), a leading Chinese company focusing on the development and commercialization of companion diagnostics (CDx), announced the signing of an extended strategic cooperation agreement. The agreement will enable expanded collaboration on important companion diagnostic targets that [...]

Crown Bioscience Expands Genomics and Next Generation Sequencing (NGS) Capabilities To Streamline Translational Biomarker Discovery Workflows

San Diego, Calif – Crown Bioscience, a JSR Life Sciences company, today announced the expansion of their state-of-the-art NGS capabilities, together with the launch of proprietary NGS panel services, providing increased opportunities for pharmaceutical partners to better understand drug mechanisms of action (MOA) and to develop predictive biomarkers for their investigational drug candidates. The newly built, [...]

Access IBO on Knowledge Center